1,463
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients

, , , , &
Pages 5916-5931 | Received 25 Apr 2021, Accepted 17 Aug 2021, Published online: 07 Sep 2021

References

  • Cersosimo F, Lonardi S, Bernardini G, et al. Tumor-associated macrophages in osteosarcoma: from mechanisms to therapy. Int J Mol Sci. 2020;21(15):5207.
  • Li Z, Li X, Xu D, et al. An update on the roles of circular RNAs in osteosarcoma. Cell Prolif. 2021;54(1):e12936.
  • Czarnecka AM, Synoradzki K, Firlej W, et al. Molecular biology of osteosarcoma. In: Cancers (Basel). 2020;12(8):2130.
  • Meazza C, Scanagatta P. Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer Ther. 2016;16(5):543–556.
  • Zhao X, Wu Q, Gong X, et al. Osteosarcoma: a review of current and future therapeutic approaches. Biomed Eng Online. 2021;20(1):24.
  • Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36(2):188–193.
  • Suhail Y, Cain MP, Vanaja K, et al. Systems biology of cancer metastasis. Cell Syst. 2019;9(2):109–127.
  • Brooks SA, Lomax-Browne HJ, Carter TM, et al. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010;112(1):3–25.
  • Wu M, Li X, Liu R, et al. Development and validation of a metastasis-related gene signature for predicting the overall survival in patients with pancreatic ductal adenocarcinoma. J Cancer. 2020;11(21):3–25.
  • Liu J, Jiang C, Xu C, et al. Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma. Cancer Cell Int. 2021;21(1):101.
  • Zheng Z, Deng W, Yang J. Identification of 5-gene signature improves lung adenocarcinoma prognostic stratification based on differential expression invasion genes of molecular subtypes. Biomed Res Int. 2020;2020:8832739.
  • Bishop MW, Janeway KA, Gorlick R. Future directions in the treatment of osteosarcoma. Curr Opin Pediatr. 2016;28(1):26–33.
  • Yuan H, Yan M, Zhang G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900–D8.
  • Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573.
  • Wang J, Vasaikar S, Shi Z, et al. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 2017;45(W1):W130–W7.
  • Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612.
  • Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.
  • Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.
  • Goh TS, Lee JS, Il Kim J, et al. Prognostic scoring system for osteosarcoma using network-regularized high-dimensional Cox-regression analysis and potential therapeutic targets. J Cell Physiol. 2019;234(8):13851–13857.
  • Zhang H, Guo L, Zhang Z, et al. Co-expression network analysis identified gene signatures in osteosarcoma as a predictive tool for lung metastasis and survival. J Cancer. 2019;10(16):3706–3716.
  • Chao-Yang G, Rong T, Yong-Qiang S, et al. Prognostic signatures of metabolic genes and metabolism-related long non-coding RNAs accurately predict overall survival for osteosarcoma patients. Front Cell Dev Biol. 2021;9:644220.
  • Xiao B, Liu L, Li A, et al. Identification and verification of immune-related gene prognostic signature based on ssGSEA for osteosarcoma. Front Oncol. 2020;10:607622.
  • Li LQ, Zhang LH, Zhang Y, et al. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients. Aging (Albany NY). 2020;12:22906–22926.
  • Zhu N, Hou J, Ma G, et al. Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma. Cancer Cell Int. 2020;20(1):259.
  • Fu Y, Bao Q, Liu Z, et al. Development and validation of a hypoxia-associated prognostic signature related to osteosarcoma metastasis and immune infiltration. Front Cell Dev Biol. 2021;9:633607.
  • Zhang J, Xi J, Huang P, et al. Comprehensive analysis identifies potential ferroptosis-associated mRNA therapeutic targets in ovarian cancer. Front Med (Lausanne). 2021;8:644053.
  • Wang Z, Wang Z, Li B, et al. Innate immune cells: a potential and promising cell population for treating osteosarcoma. Front Immunol. 2019;10:1114.
  • Heymann MF, Schiavone K, Heymann D. Bone sarcomas in the immunotherapy era. Br J Pharmacol. 2020;178(9):1955-1972.
  • Deng W, Wang L, Xiong Y, et al. The novel secretory protein CGREF1 inhibits the activation of AP-1 transcriptional activity and cell proliferation. Int J Biochem Cell Biol. 2015;65:32–39.
  • Zietkiewicz E, Nitka B, Voelkel K, et al. Population specificity of the DNAI1 gene mutation spectrum in primary ciliary dyskinesia (PCD). Respir Res. 2010;11(1):174.
  • Chen J, Guo X, Zeng G, et al. Transcriptome analysis identifies novel prognostic genes in osteosarcoma. Comput Math Methods Med. 2020;2020:8081973.
  • Tian L, McClafferty H, Knaus HG, et al. Distinct acyl protein transferases and thioesterases control surface expression of calcium-activated potassium channels. J Biol Chem. 2012;287(18):14718–14725.
  • Chen X, Hu L, Yang H, et al. DHHC protein family targets different subsets of glioma stem cells in specific niches. J Exp Clin Cancer Res. 2019;38(1):25.